Stay updated with breaking news from World Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Argenx's launch of Vyvgart (efgartigimod) has been a success, with global first-year revenue of ~$400 million USD. As the second biologic...
/PRNewswire/ -- According to Biogen's earnings call on Wednesday, February 15, 2023, sales for its multiple sclerosis (MS) franchise are down for the third...
/PRNewswire/ -- The patient switch territory is evolving as more agents become available. Spherix's RealWorld Dynamix™ report allows for an inside look into...
/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists' perceptions and...
/PRNewswire/ -- With SGLT2 inhibitors increasingly becoming the standard of care for diabetic and non-diabetic CKD patients, the broader CKD treatment has...